Novo Nordisk A/S - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US6701002056
35,82 € ↓ -1,80 (-4,78%)
2026-06-05
DEL PRIS
SecurityDE:NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)
InstitutionRock Point Advisors, LLC
Latest Disclosed Ownership6,700 shares
Latest Disclosed Value $ 246,225
Rock Point Advisors, LLC reports 2.19% decrease in ownership of NOVA / Novo Nordisk A/S - Depositary Receipt (Common Stock)

On May 14, 2026 - Rock Point Advisors, LLC filed a 13F-HR form disclosing ownership of 6,700 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock) (DE:NOVA) valued at $211,385 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 4, 2026 disclosing 6,850 shares of Novo Nordisk A/S - Depositary Receipt (Common Stock). This represents a change in shares of -2.19% during the quarter. The current value of the position is $239,994 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F Novo Nordisk A ADR 670100205 6,700 -150 -2.19 246 -29.31 0.0666
2026-02-04 2025-12-31 13F Novo Nordisk A ADR 670100205 6,850 0 0.00 349 -8.42 0.0872
2025-11-12 2025-09-30 13F Novo Nordisk A ADR 670100205 6,850 0 0.00 380 -19.49 0.1007
2025-08-14 2025-06-30 13F Novo Nordisk A ADR 670100205 6,850 -150 -2.14 473 -2.88 0.1334
2025-04-30 2025-03-31 13F Novo Nordisk A ADR 670100205 7,000 0 0.00 486 -19.27 0.1499
2025-02-13 2024-12-31 13F Novo Nordisk A ADR 670100205 7,000 -100 -1.41 602 -28.76 0.1755
2024-11-13 2024-09-30 13F Novo Nordisk A ADR 670100205 7,100 0 0.00 845 -16.58 0.2308
2024-08-08 2024-06-30 13F Novo Nordisk A ADR 670100205 7,100 0 0.00 1,013 11.20 0.3039
2024-05-10 2024-03-31 13F Novo Nordisk A ADR 670100205 7,100 -300 -4.05 912 19.08 0.2708
2024-02-08 2023-12-31 13F Novo Nordisk A ADR 670100205 7,400 0 0.00 766 13.84 0.2322
2023-11-09 2023-09-30 13F Novo Nordisk A ADR 670100205 7,400 3,700 100.00 673 12.37 0.2329
2023-08-10 2023-06-30 13F Novo Nordisk A ADR 670100205 3,700 0 0.00 599 0.1966
2023-05-10 2023-03-31 13F Novo Nordisk A ADR 670100205 3,700 -100 -2.63 1 0.2002
2023-02-09 2022-12-31 13F Novo Nordisk A ADR 670100205 3,800 0 0.00 1 -100.00 0.1779
2022-11-10 2022-09-30 13F Novo Nordisk A ADR 670100205 3,800 0 0.00 379 -10.40 0.1409
2022-08-10 2022-06-30 13F Novo Nordisk A ADR 670100205 3,800 0 0.00 423 0.24 0.1445
2022-05-10 2022-03-31 13F Novo Nordisk A ADR 670100205 3,800 0 0.00 422 -0.94 0.1258
2022-02-09 2021-12-31 13F Novo Nordisk A ADR 670100205 3,800 0 0.00 426 16.71 0.1199
2021-11-05 2021-09-30 13F Novo Nordisk A ADR 670100205 3,800 0 0.00 365 14.78 0.1069
2021-08-05 2021-06-30 13F Novo Nordisk A ADR 670100205 3,800 0 0.00 318 24.22 0.0916
2021-05-12 2021-03-31 13F Novo Nordisk A ADR 670100205 3,800 -200 -5.00 256 -8.24 0.0798
2021-02-08 2020-12-31 13F Novo Nordisk A ADR 670100205 4,000 0 0.00 279 0.36 0.0959
2020-11-10 2020-09-30 13F Novo Nordisk A ADR 670100205 4,000 0 0.00 278 6.11 0.1231
2020-08-12 2020-06-30 13F Novo Nordisk A ADR 670100205 4,000 0 0.00 262 8.71 0.1221
2020-05-07 2020-03-31 13F Novo Nordisk A ADR 670100205 4,000 -500 -11.11 241 -7.31 0.1429
2020-02-06 2019-12-31 13F Novo Nordisk A ADR 670100205 4,500 4,500 260 0.1056
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.